CopyMark Law Group
4.9/5
Drawing for QUEREXA

USPTO serial 79437357

QUEREXA

Reviewed by CopyMark Law Group

Reg. 8350254Status 700Registered
Filing date
Status date
Registration date
Jul 21, 2026
Examiner
PEISECKI, MARK A
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with QUEREXA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Goods and services

ClassDescriptionStatusFirst use
005Biochemical reagents for medical or veterinary use; biological preparations for medical use namely, mixed biological preparations for the prevention and treatment of nutritional deficiencies; biotechnological preparations for medical use, namely, mixed biological preparations for the prevention and treatment of nutritional deficiencies; dietary supplements for humans and animals; dietary supplements for pharmaceutical purposes, namely, antioxidants; dietetic food and substances adapted for medical or veterinary use; nutraceuticals for use as a dietary supplement; pharmaceutical preparations for the treatment of pain, swelling and inflammation; pharmaceutical products and preparations, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical products, medical and veterinary preparations for the treatment of cardiovascular disorders, blood pressure, neurological disorders, diabetes, stomach ulcers, urinary health, and immune system related diseases and disorders; pharmaceutical substances for the treatment of allergies; pharmaceutical products for treatment of infectious diseases and for use in oncologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 20, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 21, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 2, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 28, 2026GPNXNOTIFICATION PROCESSED BY IB—
May 27, 2026NPUBNOTICE OF PUBLICATION—
May 13, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 13, 2026OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 3, 2026PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jan 19, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 13, 2026DOCKASSIGNED TO EXAMINER—
Dec 5, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 5, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 5, 2025LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Nov 20, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance